Literature DB >> 7837238

Relative binding free energies of peptide inhibitors of HIV-1 protease: the influence of the active site protonation state.

X Chen1, A Tropsha.   

Abstract

Hydrogen bonding plays an important role in the stabilization of complexes between HIV-1 protease (HIV-1 PR) and its inhibitors. The adequate treatment of the protease active site protonation state is important for accurate molecular simulations of the protonation state is important for accurate molecular simulations of the protease-inhibitor complexes. We have applied the free energy simulation/thermodynamic cycle approach to evaluate the relative binding affinities of the S vs R isomers of the U85548E inhibitor of the protease. Several mono- and diprotonation states of the catalytic aspartic acid residues of the protease active site were considered in the course of molecular simulations. The calculated difference in binding free energy of the S vs R isomers strongly depended on the location of proton(s), but in all cases the binding free energy of the S inhibitor was higher. On the basis of our calculations, we propose that in the HIV-1 PR-inhibitor complex only one catalytic aspartic acid residue is protonated and that the binding free energy of the S isomer is ca. 2.8 kcal/mol higher than that of the R isomer. The accuracy of these predictions shall be evaluated when binding affinities of both isomers become available.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7837238     DOI: 10.1021/jm00001a009

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Does a diol cyclic urea inhibitor of HIV-1 protease bind tighter than its corresponding alcohol form? A study by free energy perturbation and continuum electrostatics calculations.

Authors:  L Wang; Y Duan; P Stouten; G V De Lucca; R M Klabe; P A Kollman
Journal:  J Comput Aided Mol Des       Date:  2001-02       Impact factor: 3.686

2.  Insights into saquinavir resistance in the G48V HIV-1 protease: quantum calculations and molecular dynamic simulations.

Authors:  Kitiyaporn Wittayanarakul; Ornjira Aruksakunwong; Suwipa Saen-oon; Wasun Chantratita; Vudhichai Parasuk; Pornthep Sompornpisut; Supot Hannongbua
Journal:  Biophys J       Date:  2004-11-12       Impact factor: 4.033

Review 3.  Identification of HIV inhibitors guided by free energy perturbation calculations.

Authors:  Orlando Acevedo; Zandrea Ambrose; Patrick T Flaherty; Hadega Aamer; Prashi Jain; Somisetti V Sambasivarao
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Insights into the functional role of protonation states in the HIV-1 protease-BEA369 complex: molecular dynamics simulations and free energy calculations.

Authors:  Jianzhong Chen; Maoyou Yang; Guodong Hu; Shuhua Shi; Changhong Yi; Qinggang Zhang
Journal:  J Mol Model       Date:  2009-03-18       Impact factor: 1.810

5.  Predicting relative binding affinities of non-peptide HIV protease inhibitors with free energy perturbation calculations.

Authors:  M A McCarrick; P A Kollman
Journal:  J Comput Aided Mol Des       Date:  1999-03       Impact factor: 3.686

6.  A preference-based free-energy parameterization of enzyme-inhibitor binding. Applications to HIV-1-protease inhibitor design.

Authors:  A Wallqvist; R L Jernigan; D G Covell
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

7.  Insights into the structural function of the complex of HIV-1 protease with TMC-126: molecular dynamics simulations and free-energy calculations.

Authors:  Dan Li; Ju-Guang Han; Hang Chen; Liang Li; Run-Ning Zhao; Guang Liu; Yuhua Duan
Journal:  J Mol Model       Date:  2011-08-18       Impact factor: 1.810

8.  Energetic basis for drug resistance of HIV-1 protease mutants against amprenavir.

Authors:  Parimal Kar; Volker Knecht
Journal:  J Comput Aided Mol Des       Date:  2012-02-14       Impact factor: 3.686

9.  Investigation on the mechanism for the binding and drug resistance of wild type and mutations of G86 residue in HIV-1 protease complexed with Darunavir by molecular dynamic simulation and free energy calculation.

Authors:  Dan Li; Ying Zhang; Run-Ning Zhao; Song Fan; Ju-Guang Han
Journal:  J Mol Model       Date:  2014-02-14       Impact factor: 1.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.